...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.
【24h】

Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.

机译:鼻腔和鼻旁鼻窦恶性肿瘤的术后强度调节放疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To evaluate the clinical outcome and toxicity of post-operative intensity-modulated radiotherapy (IMRT) for malignancies of the nasal cavity and paranasal sinuses. METHODS AND MATERIALS: Twenty-five patients with histological proven cancer of the paranasal sinuses (n=21) or nasal cavity (n=4) were post-operatively treated with IMRT at the Leuven department to a total dose of 60 Gy (n=15) or 66 Gy (n=10). Both acute and chronic toxicity were prospectively scored in all patients. RESULTS: Median follow-up was 27 months (range: 12-47 months) among surviving patients. The actuarial 2-year local control (LC), overall survival (OS) and disease-free survival (DFS) rates were 81%, 88% and 77%, respectively. One patient developed isolated distant metastasis, while none of the patients developed regional failure. No grade 3 or 4 toxicity was reported, either acute or chronic. No radiation-induced blindness or brain necrosis was reported to date, although longer follow-up has to be awaited for definitiveresults. CONCLUSION: Post-operative IMRT for sinonasal cancer resulted in similar local control and survival rates as conventional or 3D-conformal radiotherapy techniques, and was associated with little acute toxicity. Longer follow-up is necessary to confirm the lack of late complications.
机译:目的:评估术后强度调节放疗(IMRT)治疗鼻腔和鼻旁鼻窦恶性肿瘤的临床疗效和毒性。方法和材料:在鲁汶医院对25例经组织学证实为鼻旁窦癌(n = 21)或鼻腔(n = 4)的患者进行IMRT术后治疗,总剂量为60 Gy(n = 15)或66 Gy(n = 10)。在所有患者中均对急性和慢性毒性进行了评分。结果:幸存的患者中位随访时间为27个月(范围:12-47个月)。精算2年局部控制(LC),总生存(OS)和无病生存(DFS)的比率分别为81%,88%和77%。一名患者发生了孤立的远处转移,而所有患者均未出现区域性衰竭。尚无急性或慢性的3级或4级毒性报告。迄今为止,尚无放射性致盲或脑坏死的报道,尽管仍需等待更长的随访时间才能获得明确的结果。结论:鼻窦癌术后IMRT的局部控制和生存率与常规或3D保形放射治疗技术相似,并且几乎没有急性毒性。需要更长的随访时间以确认没有后期并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号